Surrey, UK- Zimbabwean scientist Moses Murandu has struck again, this time with the shocking healing of a woman with 15-year-old ulcers whose amputation has now been dramatically reversed.
Last week saw, the elderly woman (son and daughter pictured), whose right leg would have been chopped off by now, being announced to by her local doctor that the previously scheduled amputation on her right leg has since been reversed due to a phenomenal recovery through Murandu’s revolutionary Medsugar method. ALSO READ- Moses Murandu Jets Into Zimbabwe for Free Public Seminars
ZimEye.com witnessed a senior practitioner at St Peters Hospital breaking the news, “we shall now do a bypass,” because the wounds have had a sudden boost of a healthy flesh build over where the wounds once were.
The wounds started way back in 2000 and ever since then worsened while also throwing a pungent stench that over the years used to fill the whole house, her daughter Shelly Davies told ZimEye.com.
It was by some luck that sometime in September, Shelley bumped into Murandu’s news articles on the internet that she contacted him, and the rest was history. A simple applying of Murandu’s Medsugar dressing led to the wounds’ healing up in a matter of a few days.
Shelly told reporters her mother “had ulcers on both left and right legs. We found the articles on Moses, and I decided I would give a try on my mum, I have nothing to lose.
“And so here we are 6, 7 weeks down the road and her ulcers are healing and she is no longer going to have an amputation,” she said.
The mother adding her own voice, said she now wants the British government to promptly “consider the Medsugar method for the NHS (National Health Service) as this will save a lot money.” VIDEO LOADING….
Over 70 such patients have been healed through Murandu’s procedure over the last 5 years. VIDEO :
Meanwhile Murandu is reportedly in Zimbabwe and will be sharing his knowledge with his countrymen at key universities, the ZEGU university in Bindura (10am, 7th December), University of Zimbabwe (1pm to 2pm, 9th Dec) and African University Mutare (8-9am 11th Dec).
9 Replies to “Amazing Miracle: Zim Scientist Strikes Again: “Leg Chop Off” Reversed Instantly”
Comments are closed.
Because the giant drugs companies don’t like it and will do everything possible to surpress its advancement. The medical world and NHS are run by cartels out to milk the system.
This is a treatment the NHS is not going to adopt, why, because their business partners and government ministers’ contracts to supply more expensive treatments will all collapse and they will be forced to close shop. You think Pfizer would go out of business without a fight, lets wait and see.
PubMedSearchClick to search
↓ Full text
Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study.
Murandu M, et al. J Wound Care. 2011.
Show full citation
Abstract
OBJECTIVE: To determine the in vitro antimicrobial efficacy of three types of sugar and conduct a pilot clinical study with a view to developing a protocol for a randomised controlled trial (RCT).
METHOD: In the in vitro studies three types of granulated sugar (Demerara, granulated beet sugar and granulated cane sugar) were tested to determine their minimum inhibitory concentrations (MICs) against 18 Gram-negative and Gram-positive bacteria in a micro-titre broth dilution assay; growth inhibition of Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa in different concentrations of sugar (0.38-25%) was also tested over 12-hours in an agar diffusion assay. The pilot clinical study selected patients from a vascular surgical ward and a vascular outpatient department. All had acute or chronic exuding wounds, some of which were infected. White granulated sugar was applied to the wounds. The following parameters were assessed: surface area; wound characteristics including pain, malodour, appearance (slough/granulation); exudate level; pain level and bacterial load. Patients with diabetes had their blood sugar levels checked daily. All patients completed a short health questionnaire at the start and end of the study. Staff completed a satisfaction questionnaire at the end of the study. The study period was 21 days.
RESULTS: In vitro tests demonstrated that sugar inhibits bacterial growth. All three types of sugars had MICs ranging from 6-25% in the bacterial strains tested. The diffusion tests showed that strains were able to grow well in low concentrations of sugar but were completely inhibited in higher concentrations. The two granulated sugars were found to be slightly more effective than Demerara sugar, so the latter was excluded from the clinical pilot study. Twenty-two patients (20 inpatients and two outpatients) with sloughy or necrotic wounds were recruited into the clinical study. Two patients had MRSA and two had Staphylococcus colonisation at baseline. Blood sugar levels remained stable in the seven patients with insulin-dependent diabetes mellitus. All wounds were clean/debrided in a mean of 11.13 days. Pain and malodour reduced markedly. Patient and staff surveys revealed overwhelming support for the sugar therapy.
CONCLUSION: The pilot study achieved its aim of developing a protocol for a RCT. Preliminary data suggest that sugar is an effective wound cleansing and is safe to use in patients with insulin-dependent diabetes. In vitro studies demonstrate that sugar inhibits bacterial growth.
CONFLICT OF INTEREST: None.
PMID 21647066 [PubMed – indexed for MEDLINE]
Full text
Full text at journal site
Similar articles
The effect of a cellulose dressing and topical vancomycin on methicillin-resistant Staphylococcus aureus (MRSA) and Gram-positive organisms in chronic wounds: a case series.
Albaugh KW, et al. Ostomy Wound Manage. 2013.
Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing.
Clinical trial
Edmondson M, et al. Int Wound J. 2011.
Bacteriology of war wounds at the time of injury.
Murray CK, et al. Mil Med. 2006.
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds.
Review article
Gurusamy KS, et al. Cochrane Database Syst Rev. 2013.
Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Review article
Zhanel GG, et al. Am J Clin Dermatol. 2008.
See all
Full website NIH NLM NCBI Help
PubMedSearchClick to search
↓ Full text
Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study.
Murandu M, et al. J Wound Care. 2011.
Show full citation
Abstract
OBJECTIVE: To determine the in vitro antimicrobial efficacy of three types of sugar and conduct a pilot clinical study with a view to developing a protocol for a randomised controlled trial (RCT).
METHOD: In the in vitro studies three types of granulated sugar (Demerara, granulated beet sugar and granulated cane sugar) were tested to determine their minimum inhibitory concentrations (MICs) against 18 Gram-negative and Gram-positive bacteria in a micro-titre broth dilution assay; growth inhibition of Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa in different concentrations of sugar (0.38-25%) was also tested over 12-hours in an agar diffusion assay. The pilot clinical study selected patients from a vascular surgical ward and a vascular outpatient department. All had acute or chronic exuding wounds, some of which were infected. White granulated sugar was applied to the wounds. The following parameters were assessed: surface area; wound characteristics including pain, malodour, appearance (slough/granulation); exudate level; pain level and bacterial load. Patients with diabetes had their blood sugar levels checked daily. All patients completed a short health questionnaire at the start and end of the study. Staff completed a satisfaction questionnaire at the end of the study. The study period was 21 days.
RESULTS: In vitro tests demonstrated that sugar inhibits bacterial growth. All three types of sugars had MICs ranging from 6-25% in the bacterial strains tested. The diffusion tests showed that strains were able to grow well in low concentrations of sugar but were completely inhibited in higher concentrations. The two granulated sugars were found to be slightly more effective than Demerara sugar, so the latter was excluded from the clinical pilot study. Twenty-two patients (20 inpatients and two outpatients) with sloughy or necrotic wounds were recruited into the clinical study. Two patients had MRSA and two had Staphylococcus colonisation at baseline. Blood sugar levels remained stable in the seven patients with insulin-dependent diabetes mellitus. All wounds were clean/debrided in a mean of 11.13 days. Pain and malodour reduced markedly. Patient and staff surveys revealed overwhelming support for the sugar therapy.
CONCLUSION: The pilot study achieved its aim of developing a protocol for a RCT. Preliminary data suggest that sugar is an effective wound cleansing and is safe to use in patients with insulin-dependent diabetes. In vitro studies demonstrate that sugar inhibits bacterial growth.
CONFLICT OF INTEREST: None.
PMID 21647066 [PubMed – indexed for MEDLINE]
Full text
Full text at journal site
Similar articles
The effect of a cellulose dressing and topical vancomycin on methicillin-resistant Staphylococcus aureus (MRSA) and Gram-positive organisms in chronic wounds: a case series.
Albaugh KW, et al. Ostomy Wound Manage. 2013.
Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing.
Clinical trial
Edmondson M, et al. Int Wound J. 2011.
Bacteriology of war wounds at the time of injury.
Murray CK, et al. Mil Med. 2006.
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds.
Review article
Gurusamy KS, et al. Cochrane Database Syst Rev. 2013.
Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Review article
Zhanel GG, et al. Am J Clin Dermatol. 2008.
See all
Full website NIH NLM NCBI Help
Why is it that this breakthrough is not featuring in medical journals if so please reporter update us because everything to do with medicine has to be research based using the industry standards and it would have to be peer reviewed
Ndopaunonzwa rimwe hure richiti varume vekuNigeria ndovaneyese hanzi vakadzidza plus vanotsvaga cash blah blah hanzi veku Zim vanonhuwa
u have olready made an uninformed conclusion …..wy cant yu go to th seminars n find out
MedSugar? If there is any sugar element in this product, as the title would suggest, then it’s not going to help diabetics, is it? It may have worked in this particular instance, but it may not be the “miracle cure” for all that it is purporting to be.
Maybe you need to read more
Funny that I have not heard of this guy (in the UK)